ARLZ Aralez Pharmaceuticals Inc.

1.36
-0.01  -1%
Previous Close 1.37
Open 1.35
Price To book 0.94
Market Cap 89.55M
Shares 65,845,000
Volume 240,197
Short Ratio 3.71
Av. Daily Volume 1,346,100

SEC filingsSee all SEC filings

  1. 8-K - Current report 17839970
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 17827293
  3. 8-K - Current report 17824425
  4. 8-K - Current report 17823142
  5. 8-K - Current report 17810593

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved April 30, 2010.
VIMOVO
Gastric ulcers
Approval announced September 15, 2016.
YOSPRALA (PA32540/PA8140)
Secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers

SEC Filings

  1. 8-K - Current report 17839970
  2. 10-Q - Quarterly report [Sections 13 or 15(d)] 17827293
  3. 8-K - Current report 17824425
  4. 8-K - Current report 17823142
  5. 8-K - Current report 17810593
  6. 8-K - Current report 17807132
  7. 8-K - Current report 17756086
  8. RW WD - Withdrawal of Registration Withdrawal Request 17712951
  9. DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 17710319
  10. 8-K - Current report 17710249